El-Safa EA, Fredericks S, Macphee I, Holt DW, Johnston A.
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. Transplant Proc. 2006 Dec;38(10):3327-30.
Johnston A, He X, Holt DW.
Bioequivalence of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil: A Meta-Analysis of Three Studies in Stable Renal Transplant Recipients. Transplantation. 2006 Dec 15;82(11):1413-1418.
Kenyon SL, Button J, Perella P, McKeown DA, Holt DW.
An herbal remedy for impotence: more than was bargained for. J Clin Pharmacol. 2006 Nov;46(11):1379-81.
Fredericks S, Moreton M, Reboux S, Carter ND, Goldberg L, Holt DW, MacPhee IA.
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. Transplantation. 2006 Sep 15;82(5):705-8.
Fredericks S, Bertomeu-Gonzalez V, Petrovic I, Holt DW, Kaski JC.
Comment on immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem. 2006 Aug;52(8):1619-20. No abstract available.
Kaski JC, Holt DW.
Pregnancy-associated plasma protein-A and cardiovascular risk.
Eur Heart J. 2006 Jul;27(14):1637-9. Epub 2006 Jun 21. No abstract available.
van Gelder T, Le Meur Y, Shaw LM, Oellerich M, DeNofrio D, Holt C, Holt DW, Kaplan B, Kuypers D, Meiser B, Toenshoff B, Mamelok RD.
Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006 Apr;28(2):145-54.
MacPhee IA, Fredericks S, Holt DW.
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation? Expert Opin Pharmacother. 2005 Dec;6(15):2593-605.
Kenyon SL, Ramsey JD, Lee T, Johnston A, Holt DW.
Analysis for identification in amnesty bin samples from dance venues. Ther Drug Monit. 2005 Dec;27(6):793-8.
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. Transplant Proc. 2006 Dec;38(10):3327-30.
Johnston A, He X, Holt DW.
Bioequivalence of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil: A Meta-Analysis of Three Studies in Stable Renal Transplant Recipients. Transplantation. 2006 Dec 15;82(11):1413-1418.
Kenyon SL, Button J, Perella P, McKeown DA, Holt DW.
An herbal remedy for impotence: more than was bargained for. J Clin Pharmacol. 2006 Nov;46(11):1379-81.
Fredericks S, Moreton M, Reboux S, Carter ND, Goldberg L, Holt DW, MacPhee IA.
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. Transplantation. 2006 Sep 15;82(5):705-8.
Fredericks S, Bertomeu-Gonzalez V, Petrovic I, Holt DW, Kaski JC.
Comment on immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem. 2006 Aug;52(8):1619-20. No abstract available.
Kaski JC, Holt DW.
Pregnancy-associated plasma protein-A and cardiovascular risk.
Eur Heart J. 2006 Jul;27(14):1637-9. Epub 2006 Jun 21. No abstract available.
van Gelder T, Le Meur Y, Shaw LM, Oellerich M, DeNofrio D, Holt C, Holt DW, Kaplan B, Kuypers D, Meiser B, Toenshoff B, Mamelok RD.
Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006 Apr;28(2):145-54.
MacPhee IA, Fredericks S, Holt DW.
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation? Expert Opin Pharmacother. 2005 Dec;6(15):2593-605.
Kenyon SL, Ramsey JD, Lee T, Johnston A, Holt DW.
Analysis for identification in amnesty bin samples from dance venues. Ther Drug Monit. 2005 Dec;27(6):793-8.
Bioanalytics and Forensic Toxicology